Ferrostatin-1 inhibits osteoclast differentiation and prevents osteoporosis by suppressing lipid peroxidation
Abstract Background Osteoporosis (OP) is a systemic disease characterized by low bone mass. New progress has been made in the study of OP, such as lipid peroxidation. However, the role of lipid peroxides in osteoclast differentiation is still unclear. Methods Bone marrow macrophages (BMMs) were extr...
Saved in:
Main Authors: | Wenbo Xu, Shiyan Lv, Xiaoyan Wang, Chengchao Song, Chunyang Xi, Jinglong Yan |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | Journal of Orthopaedic Surgery and Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13018-025-05544-2 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
miR-208a-3p discriminates osteoporosis, predicts fracture, and regulates osteoclast activation through targeting STC1
by: Hongbing Qian, et al.
Published: (2025-01-01) -
Dual functional hydrogel of osteoclastic-inhibition and osteogenic-stimulation for osteoporotic bone defect regeneration
by: Lei Yu, et al.
Published: (2025-04-01) -
Ketogenic diet and β-hydroxybutyrate in osteoporosis: current progress and controversy
by: Changfang Luo, et al.
Published: (2025-01-01) -
Unveiling the role of melatonin‐related gene CSNK1D in osteoclastogenesis and its implications for osteoporosis treatment
by: Jiewen Zhang, et al.
Published: (2025-02-01) -
Lipid peroxidation and sarcopenia: molecular mechanisms and potential therapeutic approaches
by: Yifan Lu, et al.
Published: (2025-02-01)